Open Your FREE Demat Account Now!

N/A
indicator

Bse Dollex 30

1D
1M
3M
6M
1Y
5Y
empty graph

Bse Dollex 30 Performance

Low

₹6,372.36

High

₹6,456.91

52 Week Range

Low

₹6,050.37

High

₹7,966.63

Previous Close ₹6,375.90
Day's Range ₹6,372.36 - ₹6,456.91
Open ₹6,427.14
52 Week Range ₹6,050.37 - ₹7,966.63
Volume 0

All Indices

Index Name Market Value 52W High 52W Low
Nifty 50 22830.0 26373.20 22179.90
Nifty IT 32152.9 40301.40 25699.10
Nifty Next 50 67533.05 75000.40 59896.10
NIFTY50 USD Index 8351.65 10443.40 7839.85
Nifty Bank 55014.15 61764.85 49954.85
NIFTY Midcap 100 57503.1 64450.90 52032.85
Nifty 500 21833.75 24144.20 20385.65
Nifty Midcap 50 16476.15 18500.95 14804.55
Nifty 100 23769.7 26975.15 22720.45
Nifty FMCG 43699.1 57445.20 43442.30

Latest News

Oct
21
2026
EQUITY Posted on Oct 21st 2026

Tamboli Industries informs about board meeting

In accordance with Regulation 29 read with Regulation 47 of the SEBI (Listing Obligations and Disclosures Requirements) Regulations 2015, Tamboli Industries has informed that a meeting of the Board of Directors of the Company will be held on Thursday November 5,2026 to consider and take on record Un-audited Quarterly Financial results of the Company for July-September 2026 quarter and half year ended on September 30,2026.

The above information is a part of company’s filings submitted to BSE.

Read More
Oct
21
2026
EQUITY Posted on Oct 21st 2026

Epigral informs about analyst meet

Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Epigral has informed that the Investor / Analyst Plant Visit on Thursday, 22nd October, 2026 at Dahej, Gujarat. No unpublished price sensitive information will be shared/discussed during the plant visit with investor / analyst. 
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
21
2026
EQUITY Posted on Oct 21st 2026

Dr. Reddy’s Laboratories informs about press release

Dr. Reddy’s Laboratories has informed that it enclosed a Press Release ‘Dr. Reddy’s Receives DCGI Approval for Zytorvi® (toripalimab) in Advanced Esophageal Squamous Cell Carcinoma, Its Second Approved Indication in India’.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
21
2026
EQUITY Posted on Oct 21st 2026

Larsen & Toubro informs about press release

Larsen & Toubro has informed that it enclosed a copy of Press Release that is being issued by the Company today, titled ‘L&T Wins Orders (*Large) in New Delhi and Andhra Pradesh’.
The above information is a part of company’s filings submitted to BSE.
Read More
Oct
21
2026
EQUITY Posted on Oct 21st 2026

Tips Music informs about transcript of earnings call

In terms of the Regulation 30 of the Securities and Exchange Board of India (Listing Obligations & Disclosure Requirements) Regulations, 2015, Tips Music has informed that it enclosed the transcript of earnings conference call on Unaudited Financial Results for the quarter and half year ended September 30, 2026 held on Thursday, October 15, 2026.
The above information is a part of company’s filings submitted to BSE.
Read More
no-content No Records Found

Sign in to Unlock Offers!

Explore Loans, Cards, Investments & Insurance

No SPAM We don't SPAM
Right Hand Side Image
STEP 1/2

Open Demat Account today!

+91

Enter mobile number

Invalid mobile number

Enter Full Name

Invalid Full Name

Frequently Asked Questions

What is the Previous Close of DOL30 index?

The previous close of DOL30 index is ₹6375.9 as of 2026-10-21.

The total volume of DOL30 index is 0.00 as of 2026-10-21.

The percentage change in value of DOL30 index is -0.15% as of 2026-10-21.

The absolute increase in DOL30 index value since the previous trading day is ₹-9.31 as of 2026-10-21.

A stock reaching its 52-week high indicates it has attained its highest price point in the past year. This milestone may signal strong performance and positive investor sentiment. Please note that investments are subject to market risks.

View More
Verification required
close

Enter the One Time Password (OTP)

Sent to ********99

Edit Number
Enter valid OTP
Field should not be blank
You have exhausted your OTP attempts try again after 10 min

Request another in 60s

Resend OTP

secure   100% safe and secure

Disclaimer

All content and research information displayed on the Site, are obtained from our partner Accord Fintech Private Limited. an authorized data feed vendor of BSE/NSE/MCX/NCDEX exchange. The data is provided on ‘As-Is’ basis and is not a live data feed but a feed with 15 minutes delay or more. Bajaj Markets does not warrant accuracy, completeness, timely availability of the information and data available on the Site. Past performance, when presented, is purely for reference purposes and is not a guarantee of similar future results.

The Services offered on the Site does not constitute investment advice in any manner whatsoever. You shall be solely responsible for any investment decisions made by placing reliance on the information provided on the Site.

Bajaj Markets partners with financial services entities for sourcing leads for services such as DEMAT accounts etc. In case you wish to avail the services, you shall be redirected to partners platform and shall be bound by the terms and conditions, privacy policy governing the said platform. 

Invalid Mobile Number

Invalid Full Name

Home
Home
ONDC_Shopping
Shopping
Loan
Loan Offers
My Accounts
My Accounts
Explore
Explore